Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tara K. Sealy is active.

Publication


Featured researches published by Tara K. Sealy.


PLOS Pathogens | 2009

Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats

Jonathan S. Towner; Brian R. Amman; Tara K. Sealy; Serena A. Carroll; James A. Comer; Alan Kemp; Robert Swanepoel; Christopher D. Paddock; Stephen Balinandi; Marina L. Khristova; Pierre Formenty; César G. Albariño; David Miller; Zachary Reed; John Kayiwa; James N. Mills; Deborah Cannon; Patricia W. Greer; Emmanuel Byaruhanga; Eileen C. Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W. Tappero; Sherif R. Zaki; Thomas G. Ksiazek; Stuart T. Nichol; Pierre E. Rollin

In July and September 2007, miners working in Kitaka Cave, Uganda, were diagnosed with Marburg hemorrhagic fever. The likely source of infection in the cave was Egyptian fruit bats (Rousettus aegyptiacus) based on detection of Marburg virus RNA in 31/611 (5.1%) bats, virus-specific antibody in bat sera, and isolation of genetically diverse virus from bat tissues. The virus isolates were collected nine months apart, demonstrating long-term virus circulation. The bat colony was estimated to be over 100,000 animals using mark and re-capture methods, predicting the presence of over 5,000 virus-infected bats. The genetically diverse virus genome sequences from bats and miners closely matched. These data indicate common Egyptian fruit bats can represent a major natural reservoir and source of Marburg virus with potential for spillover into humans.


Science | 2009

Discovery of Swine as a Host for the Reston ebolavirus

Roger W. Barrette; Samia Metwally; Jessica M. Rowland; Lizhe Xu; Sherif R. Zaki; Stuart T. Nichol; Pierre E. Rollin; Jonathan S. Towner; Wun Ju Shieh; Brigid Batten; Tara K. Sealy; C. Carrillo; Karen Moran; Alexa J. Bracht; Gregory A. Mayr; Magdalena Sirios-Cruz; Davinio P. Catbagan; Elizabeth A. Lautner; Thomas G. Ksiazek; William White; Michael T. McIntosh

Not Reston at All Reston ebolavirus is named, mistakenly perhaps, for Reston, Virginia, where it was discovered in the 1970s in imported macaques. After some alarm it was found not to be virulent in humans, uniquely among the ebola viruses, which are characteristically fatal causing a horrific spectrum of symptoms. Using a panviral detection assay, Reston ebolavirus has been rediscovered by Barrette et al. (p. 204) in domesticated pigs in the Philippines in association with other viruses that cause respiratory illness. The strains involved are closely related to the original macaque strain and, given how little variance there is among the viruses, it appears that it is freely circulating between these species possibly, like several other zoonotic viruses, having a reservoir in bats. Serological assays indicated that farm workers have become infected, although no obvious symptoms of human disease have been reported. Respiratory infections in pigs in the Philippines are associated with a cocktail of viruses, including a monkeys filovirus. Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic fatal outbreaks of disease in humans and nonhuman primates have given impetus to identification of host tropisms and potential reservoirs. Domestic swine in the Philippines, experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome, have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member of Filoviridae that has not been associated with disease in humans, its emergence in the human food chain is of concern. REBOV isolates were found to be more divergent from each other than from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been circulating since, and possibly before, the initial discovery of REBOV in monkeys.


Journal of Virology | 2006

Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola

Jonathan S. Towner; Marina L. Khristova; Tara K. Sealy; Martin J. Vincent; Bobbie R. Erickson; Darcy A. Bawiec; Amy L. Hartman; James A. Comer; Sherif R. Zaki; Ute Ströher; Filomena Gomes da Silva; Fernando del Castillo; Pierre E. Rollin; Thomas G. Ksiazek; Stuart T. Nichol

ABSTRACT In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different (∼7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.


The New England Journal of Medicine | 2017

Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report

Gibrilla F. Deen; Barbara Knust; Nathalie Broutet; Foday Sesay; Pierre Formenty; Christine Ross; Anna Thorson; Thomas Massaquoi; Jaclyn E. Marrinan; Elizabeth Ervin; Amara Jambai; Suzanna L. R. McDonald; Kyle T. Bernstein; Alie Wurie; Marion S. Dumbuya; Neetu Abad; Baimba Idriss; Teodora Wi; Sarah D. Bennett; Tina Davies; Faiqa K. Ebrahim; Elissa Meites; Dhamari Naidoo; Samuel Smith; Anshu Banerjee; Bobbie R. Erickson; Aaron C. Brault; Kara N. Durski; Jorn Winter; Tara K. Sealy

BACKGROUND Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse‐transcriptase–polymerase‐chain‐reaction (RT‐PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT‐PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle‐threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle‐threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS These data showed the long‐term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.)


PLOS Pathogens | 2012

Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection

Brian R. Amman; Serena A. Carroll; Zachary Reed; Tara K. Sealy; Stephen Balinandi; Robert Swanepoel; Alan Kemp; Bobbie R. Erickson; James A. Comer; Shelley Campbell; Deborah Cannon; Marina L. Khristova; Patrick Atimnedi; Christopher D. Paddock; Rebekah J. Kent Crockett; Timothy D. Flietstra; Kelly L. Warfield; Robert Unfer; Edward Katongole-Mbidde; Robert Downing; Jordan W. Tappero; Sherif R. Zaki; Pierre E. Rollin; Thomas G. Ksiazek; Stuart T. Nichol; Jonathan S. Towner

Marburg virus (family Filoviridae) causes sporadic outbreaks of severe hemorrhagic disease in sub-Saharan Africa. Bats have been implicated as likely natural reservoir hosts based most recently on an investigation of cases among miners infected in 2007 at the Kitaka mine, Uganda, which contained a large population of Marburg virus-infected Rousettus aegyptiacus fruit bats. Described here is an ecologic investigation of Python Cave, Uganda, where an American and a Dutch tourist acquired Marburg virus infection in December 2007 and July 2008. More than 40,000 R. aegyptiacus were found in the cave and were the sole bat species present. Between August 2008 and November 2009, 1,622 bats were captured and tested for Marburg virus. Q-RT-PCR analysis of bat liver/spleen tissues indicated ∼2.5% of the bats were actively infected, seven of which yielded Marburg virus isolates. Moreover, Q-RT-PCR-positive lung, kidney, colon and reproductive tissues were found, consistent with potential for oral, urine, fecal or sexual transmission. The combined data for R. aegyptiacus tested from Python Cave and Kitaka mine indicate low level horizontal transmission throughout the year. However, Q-RT-PCR data show distinct pulses of virus infection in older juvenile bats (∼six months of age) that temporarily coincide with the peak twice-yearly birthing seasons. Retrospective analysis of historical human infections suspected to have been the result of discrete spillover events directly from nature found 83% (54/65) events occurred during these seasonal pulses in virus circulation, perhaps demonstrating periods of increased risk of human infection. The discovery of two tags at Python Cave from bats marked at Kitaka mine, together with the close genetic linkages evident between viruses detected in geographically distant locations, are consistent with R. aegyptiacus bats existing as a large meta-population with associated virus circulation over broad geographic ranges. These findings provide a basis for developing Marburg hemorrhagic fever risk reduction strategies.


Journal of Virology | 2013

Molecular evolution of viruses of the family Filoviridae based on 97 whole genome sequences

Serena A. Carroll; Jonathan S. Towner; Tara K. Sealy; Laura K. McMullan; Marina L. Khristova; Felicity J. Burt; Robert Swanepoel; Pierre E. Rollin; Stuart T. Nichol

ABSTRACT Viruses in the Ebolavirus and Marburgvirus genera (family Filoviridae) have been associated with large outbreaks of hemorrhagic fever in human and nonhuman primates. The first documented cases occurred in primates over 45 years ago, but the amount of virus genetic diversity detected within bat populations, which have recently been identified as potential reservoir hosts, suggests that the filoviruses are much older. Here, detailed Bayesian coalescent phylogenetic analyses are performed on 97 whole-genome sequences, 55 of which are newly reported, to comprehensively examine molecular evolutionary rates and estimate dates of common ancestry for viruses within the family Filoviridae. Molecular evolutionary rates for viruses belonging to different species range from 0.46 × 10−4 nucleotide substitutions/site/year for Sudan ebolavirus to 8.21 × 10−4 nucleotide substitutions/site/year for Reston ebolavirus. Most recent common ancestry can be traced back only within the last 50 years for Reston ebolavirus and Zaire ebolavirus species and suggests that viruses within these species may have undergone recent genetic bottlenecks. Viruses within Marburg marburgvirus and Sudan ebolavirus species can be traced back further and share most recent common ancestors approximately 700 and 850 years before the present, respectively. Examination of the whole family suggests that members of the Filoviridae, including the recently described Lloviu virus, shared a most recent common ancestor approximately 10,000 years ago. These data will be valuable for understanding the evolution of filoviruses in the context of natural history as new reservoir hosts are identified and, further, for determining mechanisms of emergence, pathogenicity, and the ongoing threat to public health.


The Journal of Infectious Diseases | 2007

High-Throughput Molecular Detection of Hemorrhagic Fever Virus Threats with Applications for Outbreak Settings

Jonathan S. Towner; Tara K. Sealy; Thomas G. Ksiazek; Stuart T. Nichol

Within the past dozen years, outbreaks of filoviral hemorrhagic fever within the human population have been occurring with increasing frequency, with an average of 1 epidemic now occurring every 1-2 years. Many of the outbreaks have been large (involving >150 cases), necessitating rapid responses from the international community to help implement infection control and surveillance. This increased activity, combined with todays climate of bioterrorism threats, has heightened the need for high-throughput methodologies for specific detection of these high-hazard viruses in sophisticated laboratory setups and mobile field laboratory situations. Using Zaire Ebola virus as an example, we describe here the development of a high-throughput protocol for RNA extraction and quantitative reverse-transcription polymerase chain reaction analysis that is safe, fast, and reliable. Furthermore, the applicability of this method to an outbreak setting was demonstrated by correct analysis of >500 specimens at a field laboratory established during a recent outbreak of Marburg hemorrhagic fever in Angola.


Emerging Infectious Diseases | 2007

Pet Rodents and Fatal Lymphocytic Choriomeningitis in Transplant Patients

Brian R. Amman; Boris I. Pavlin; César G. Albariño; James A. Comer; Bobbie R. Erickson; Jennifer B. Oliver; Tara K. Sealy; Martin J. Vincent; Stuart T. Nichol; Christopher D. Paddock; Abbigail J. Tumpey; Kent D. Wagoner; R. David Glauer; Kathleen Smith; Kim A. Winpisinger; Melody S. Parsely; Phil Wyrick; Christopher H. Hannafin; Utpala Bandy; Sherif Mohammed Zaki; Pierre E. Rollin; Thomas G. Ksiazek

A unique strain of this virus was traced back to hamsters from an Ohio rodent distribution facility.


Journal of Wildlife Diseases | 2015

ORAL SHEDDING OF MARBURG VIRUS IN EXPERIMENTALLY INFECTED EGYPTIAN FRUIT BATS (ROUSETTUS AEGYPTIACUS)

Brian R. Amman; Megan E. B. Jones; Tara K. Sealy; Luke S. Uebelhoer; Brian H. Bird; JoAnn D. Coleman-McCray; Brock E. Martin; Stuart T. Nichol; Jonathan S. Towner

Abstract Marburg virus (Marburg marburgvirus; MARV) causes sporadic outbreaks of Marburg hemorrhagic fever (MHF) in Africa. The Egyptian fruit bat (Rousettus aegyptiacus) has been identified as a natural reservoir based most-recently on the repeated isolation of MARV directly from bats caught at two locations in southwestern Uganda where miners and tourists separately contracted MHF from 2007–08. Despite learning much about the ecology of MARV through extensive field investigations, there remained unanswered questions such as determining the primary routes of virus shedding and the severity of disease, if any, caused by MARV in infected bats. To answer these questions and others, we experimentally infected captive-bred R. aegyptiacus with MARV under high (biosafety level 4) containment. These experiments have shown infection profiles consistent with R. aegyptiacus being a bona fide natural reservoir host for MARV and demonstrated routes of viral shedding capable of infecting humans and other animals.


Clinical Infectious Diseases | 2016

Ebola Virus Persistence in Semen of Male Survivors

Timothy M. Uyeki; Bobbie R. Erickson; Shelley Brown; Anita K. McElroy; Deborah Cannon; Aridth Gibbons; Tara K. Sealy; Markus H. Kainulainen; Colleen S. Kraft; Aneesh K. Mehta; G. Marshall Lyon; Jay B. Varkey; Bruce S. Ribner; Richard T. Ellison; Ellie Carmody; Gerard J. Nau; Christina F. Spiropoulou; Stuart T. Nichol; Ute Ströher

We investigated the duration of Ebola virus (EBOV) RNA and infectious EBOV in semen specimens of 5 Ebola virus disease (EVD) survivors. EBOV RNA and infectious EBOV was detected by real-time RT-PCR and virus culture out to 290 days and 70 days, respectively, after EVD onset.

Collaboration


Dive into the Tara K. Sealy's collaboration.

Top Co-Authors

Avatar

Stuart T. Nichol

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jonathan S. Towner

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Brian R. Amman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Bobbie R. Erickson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Pierre E. Rollin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Thomas G. Ksiazek

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

César G. Albariño

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sherif R. Zaki

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Aridth Gibbons

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Brian H. Bird

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge